Pharmaceutical Pricing in Germany: How Is Value Determined within the Scope of AMNOG?

Price premiums, or “value,” are driven by health gain, the share of patients benefiting from a pharmaceutical, European price levels, and whether comparators are generic. No statement can be made, however, about the appropriateness of the level of price premiums.